ReportsAug 10, 2026 · after close
Fiscal periodQ2 2026
Market cap$7.33B
Consensus EPSNot covered · 3 estimates
Year-ago EPS$0.17
Expected changeNot available
Quarterly markets
What will Hims say during their next earnings call?
Trade- Testosterone94%
- Peptide89%
- FDA87%
- Wegovy78%
- Longevity78%
- Lab Testing76%
- Canada74%
- Eucalyptus72%
- Zava66%
- YourBio60%
- Wearable59%
- Europe56%
Q2 Subscribers
Full year
Subscribers
Other figures HIMS reports
9 more reported metrics with no market on them yetQ4 2024 reported
No market on this figure$168+14.3% QoQ